HomeJUBLPHARMA • NSE
add
Jubilant Pharmova Ltd
Previous close
₹1,142.30
Day range
₹1,132.10 - ₹1,149.80
Year range
₹692.90 - ₹1,309.90
Market cap
179.46B INR
Avg Volume
426.38K
P/E ratio
21.44
Dividend yield
0.44%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 19.29B | 9.68% |
Operating expense | 10.52B | 24.41% |
Net income | 1.54B | 362.12% |
Net profit margin | 7.96 | 339.04% |
Earnings per share | 9.83 | — |
EBITDA | 3.42B | 41.38% |
Effective tax rate | 26.55% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.89B | 13.84% |
Total assets | 127.56B | 10.46% |
Total liabilities | 65.18B | 6.37% |
Total equity | 62.39B | — |
Shares outstanding | 158.19M | — |
Price to book | 2.89 | — |
Return on assets | — | — |
Return on capital | 6.96% | — |
Cash Flow
Net change in cash
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 1.54B | 362.12% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1978
Headquarters
Website
Employees
5,399